Thermalin Diabetes' Grant

Thermalin Diabetes raised a round of funding on , . Investors include U.S. Small Business Administration.

Thermalin is pursuing promising product profiles that will improve insulin therapy for specific classes of patients and enable new delivery technologies. These include: Ultra-concentrated (U500) insul…

Articles about Thermalin Diabetes' Grant: